Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
3h
Hosted on MSNRezolute’s Strategic Advances in Rare Disease TherapiesRezolute, Inc. ( ($RZLT) ) has released its Q2 earnings. Here is a breakdown of the information Rezolute, Inc. presented to its investors.
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, Marketbeat ...
We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where ...
Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Scot Niglio discussing two abstracts: “Safety and efficacy of neoadjuvant immunotherapy with ...
Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.
Long-time volunteer at Northwestern Medicine Delnor Hospital in Geneva celebrates procedure that saved her heart as hospital ...
The results of an observational study from Lund University in Sweden are clear: Up to the age of 2, a more fiber-rich diet ...
President Donald Trump is pursuing changes at NIH that would result in ten of millions of dollars in funding cuts for Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results